TP53 and ovarian cancer: This is lower than TP53 mutation rates of up to 96.7% in HGSOC reported by Ahmed et al. [22], but is consistent with recent, smaller studies reporting 50–80% of ovarian cancers harbor somatic TP53 mutations [23,24].